Genetic Testing: Insurance Coverage And Life Insurance Applications

The Genetic Information Nondiscrimination Act (GINA) of 2008 prohibits health insurance companies from using genetic information to make coverage or rate decisions. However, GINA protections do not extend to life insurance, disability insurance, or long-term care insurance. This means that, in the US, there is no federal law that limits the use of genetic information by life insurance companies. As a result, life insurance companies may use genetic test results when evaluating an application for life insurance. This could lead to individuals with pre-existing conditions or genetic diseases being priced out of the market or declined coverage altogether. However, it's important to note that life insurance companies don't consider at-home DNA tests, such as ancestry tests, to be reliable. Additionally, some states have laws that provide extra consumer protections related to genetic testing and insurance.

The Genetic Information Nondiscrimination Act (GINA)

However, it's important to note that GINA does not apply to smaller employers with fewer than 15 employees, and it also does not cover other forms of insurance, such as disability insurance, long-term care insurance, or life insurance. In the case of life insurance, while GINA protections do not extend to it, the results of at-home DNA tests are generally not considered reliable by life insurance companies, and they are only interested in such tests if they include a recommendation to contact a doctor.

GINA defines "genetic information" as information about an individual's genetic tests, the genetic tests of their family members, and any genetic tests of a fetus carried by an individual or their family member. It also includes information about the manifestation of a disease or disorder in an individual's family members, often referred to as family medical history. Additionally, genetic information covers an individual's request for or receipt of genetic services or participation in clinical research that includes genetic services.

The act prohibits discrimination and harassment based on genetic information in employment. It also restricts employers and other covered entities from requesting, requiring, or purchasing genetic information, and it strictly limits the disclosure of such information. GINA makes it illegal to use genetic information when making employment decisions, such as hiring, firing, promotions, pay, job assignments, layoffs, training, and other terms or conditions of employment.

There are a few narrow exceptions to the prohibition on acquiring genetic information, such as inadvertent acquisitions, obtaining family medical history as part of health or genetic services offered on a voluntary basis, and acquiring information through publicly available documents like newspapers, as long as there is no intent to find genetic information.

GINA doesn't apply to life insurance

The Genetic Information Nondiscrimination Act (GINA) of 2008 was established to protect individuals in the USA from discrimination based on their genetic data. However, it is important to note that GINA does not apply to life insurance. While GINA prohibits health insurance providers from using genetic information to make decisions about a person's health insurance eligibility or coverage, this does not extend to life insurance.

The exclusion of life insurance from GINA's protections is a significant concern for consumer privacy advocates, who argue that there should be more regulations to limit the use of genetic information by insurance companies. This is because life insurance companies can request medical information, including the results of any genetic testing, when evaluating applications for coverage. This means that individuals who undergo genetic testing may find it more difficult to obtain life insurance or may face higher premiums due to their increased "mortality risk".

The impact of genetic testing on life insurance applications highlights the tension between an individual's desire not to be penalized for their genetic makeup and the insurance company's desire to make profitable decisions. While GINA provides essential protections in the areas of health insurance and employment, it does not extend to life insurance, leaving individuals vulnerable to potential discrimination based on their genetic information when seeking this type of coverage.

Some states, such as Florida and California, have enacted genetic privacy laws that offer additional protections. For example, Florida prohibits life insurance companies from using genetic information to deny or limit coverage or set premium rates. California's Genetic Information Privacy Act (GIPA) prohibits direct-to-consumer companies from disclosing genetic information to insurance companies. These state-level efforts provide some relief, but there is still a need for more comprehensive regulations at the federal level to fully address this issue.

Life insurance companies' interest in genetic tests

Life insurance companies are interested in genetic tests because they use the information to assess an applicant's risk factors. While federal law prohibits health insurance companies from using genetic information to make coverage decisions, this does not apply to life insurance companies.

Life insurance companies are interested in genetic tests that are ordered by medical providers, as these are considered more reliable than at-home DNA tests. They will review an applicant's medical records and ask questions about their health history and their family's health history. If an applicant has had a genetic test, they are expected to disclose this information.

In some cases, genetic test results can work in the applicant's favor. For example, if an applicant's mother had breast cancer before the age of 50, their "mortality risk" would be considered higher. However, if they took a genetic test and the markers for breast cancer were negative, their family history would be "forgiven", and their risk assessment would be lower.

Life insurance companies argue that consumers benefit when they have access to this information, as it allows them to sell insurance to as many people as possible at the lowest rate possible. However, consumer privacy advocates argue that more regulations are needed to limit the use of genetic information by insurance companies to protect privacy and prevent discrimination.

State laws and genetic privacy

While the Genetic Information Nondiscrimination Act (GINA) of 2008 prohibits health insurance companies from using genetic information to make coverage or rate decisions, it does not apply to life insurance. However, some states have laws that cover these forms of insurance. Florida is the only state that has enacted a genetic privacy law that prohibits life insurance companies from canceling, limiting, or denying coverage and from setting different premium rates based on genetic information.

In 2023, Montana, Tennessee, Texas, and Virginia joined six other states (Arizona, California, Kentucky, Maryland, Utah, and Wyoming) in enacting privacy laws for direct-to-consumer genetic testing companies. These laws create a consumer right to access and delete personal data, prohibit sharing genetic information with insurers and employers, and require companies to implement security programs to protect individuals' data. They also require companies to obtain separate express consent for marketing, research, and third-party data sharing.

Montana and Texas have additional requirements for direct-to-consumer genetic testing companies. Montana imposed data localization requirements for its residents' genetic data, while Texas established a property right for its residents over their genetic samples and data.

While these state laws provide important protections for individuals, they do not fully address emerging privacy issues, such as law enforcement access to data, children's and teens' online privacy, and transparency around changing privacy policies to accommodate new technologies like AI. As of 2024, efforts to enhance genetic privacy protections at the state and federal levels continue, with a focus on addressing these outstanding concerns.

The future of genetic testing and insurance

• Increased Use of Genetic Testing by Insurers: As genetic testing becomes more common, life insurance providers may increasingly rely on genetic data to evaluate risk and set premiums. This could lead to individuals with pre-existing conditions or genetic diseases being priced out of the market or declined coverage. However, the reliability and accuracy of at-home genetic tests have been questioned, and insurers may prefer doctor-ordered tests for risk assessment.
• Regulatory Landscape Evolution: Currently, the Genetic Information Nondiscrimination Act (GINA) of 2008 prohibits health insurance companies from using genetic information for coverage decisions, but it does not extend to life insurance, disability insurance, or long-term care insurance. The future may see the introduction of federal or state legislation addressing the use of genetic information by life insurers, similar to the moratorium implemented in the UK until 2017. Florida is the only state with a genetic privacy law prohibiting life insurers from using genetic information for coverage decisions.
• Consumer Privacy and Protection: There are concerns about consumer privacy and the potential for discrimination based on genetic information. While some states have enacted laws to protect consumers, there is no comprehensive federal legislation. The future may see increased advocacy for regulations to limit the use of genetic information by insurers, ensuring privacy and preventing discrimination.
• Impact on Insurance Markets: The availability and affordability of life insurance could be affected by genetic testing. If individuals with higher-risk genetic profiles disproportionately purchase insurance, insurers may respond by increasing rates for all customers. On the other hand, if genetic testing leads to improved diagnosis, prevention, and treatment, it could lower risks for many applicants, potentially expanding the insurance market.
• Balancing Stakeholder Interests: The future may involve a delicate balance between the interests of insurers, consumers, and policymakers. Insurers seek accurate risk assessment, while consumers want to protect their privacy and access affordable coverage. Policymakers will need to address these competing interests through legislation that ensures fairness and maintains the availability of life insurance as a social good.
• Ethical Considerations: The ethical implications of genetic testing and insurance are complex. On the one hand, genetic testing can provide valuable health insights and facilitate early diagnosis and treatment. On the other hand, there are concerns about disincentivizing genetic testing due to potential insurance implications, which could hinder disease prevention and management.

In conclusion, the future of genetic testing and insurance involves navigating ethical, legal, and social complexities. While genetic testing has the potential to revolutionize healthcare, its impact on insurance, particularly life insurance, remains uncertain. The development of regulations, consumer advocacy, and the evolution of the insurance market will shape how genetic information is utilized in the underwriting process, ultimately influencing the availability and affordability of coverage for individuals.

Frequently asked questions